DUBLIN–(BUSINESS WIRE)–The “Cold
and Sinus Medications Market in the United States” report has
been added to ResearchAndMarkets.com’s offering.
A comprehensive analysis of the U.S. Cold and Sinus Medications
industry, focusing on key trends, developments, challenges, business
opportunities, and new product activity, and offers insights and
information on the following:
- Industry trends
- Market size and performance
- Brand sales and share
- Company sales and share
- New product activity
- Retail distribution
- Regulatory developments
- Rx-to-OTC switch forecasts
- Five-year historical sales
- Five-year sales forecasts
Features user-friendly database that is fully searchable and exportable
that contains sales data, growth, share, and forecasts for hundreds of
brands and companies across more than 20 categories
Contents
The data contained in this study provides information on the entire U.S.
Cold and Sinus Medications industry sales conducted through consumer
outlets for the calendar year 2017. Some sections also occasionally
cover developments for 2018 and are noted as such.
The information in the report presents a comprehensive overview
of the industry, including data on products and companies, organized for
ready reference, as follows:
-
Executive Summary. This top-line summary highlights key 2017
information and select 2018 activities and noteworthy strategic trends
and issues. -
Products. This section gives thorough market profiles of 22 major
product categories in 7 product classes of the industry for 2016 and
2017. -
Major Companies. Profiled here are the principal companies with U.S.
Cold and Sinus Medications sales exceeding $100 million, comprising
extensive business summaries of 11 major suppliers for 2017.
Scope
This report focuses solely on products sold through domestic consumer
outlets, including those marketed via drug stores, food stores, and mass
merchandisers, in addition to non-traditional outlets, such as online,
health food stores, convenience stores, warehouse clubs, dollar stores,
and mail order, among others.
- Market data refers exclusively to sales through these outlets.
-
Direct and mail order sales are included, but sales to institutions,
such as hospitals and nursing homes, and exports are excluded. -
All market sales data are given in manufacturers’ or factory dollars,
that is, the prices received by manufacturers before wholesale and
retail mark-ups. -
All companies selling branded products are considered manufacturers in
this report, regardless of whether they have manufacturing facilities
of their own or sell products made by other companies.
The data presented in this report are believed to be
sufficiently accurate for preliminary market planning
-
However, more specific and detailed studies should be conducted before
projects that require substantial business decisions are undertaken. -
The author is pleased to assist clients on such projects through its
custom consultation capabilities, realized through over 50 years of
experience in consulting to the pharmaceutical industry.
Companies Mentioned
- Bayer Group
- Carlyle Group
- Church & Dwight
- GlaxoSmithKline
- Johnson & Johnson
- Perrigo Company
- Pfizer
- Prestige Brands
- Procter & Gamble
- Reckitt Benckiser
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/dft8s2/united_states?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Cough
and Cold Drugs